智通财经APP预告,2021年5月18日,港美股上市公司活动及香港重要财经会议信息情况如下: 04:30 ENDRA Life Sciences, Inc.(NDRA.US) ENDRA Life Sciences, Inc.(NDRA.US)2021年第一季度业绩电话会 网络转播 04:30 GAN Limited(GAN.US) G... 网页链接
$恩德拉生命科学(NDRA)$ DEF 14A Other definitive proxy statements Accession Number: 0001654954-24-008176 Act: 34 Size: 1 MB 网页链接
$恩德拉生命科学(NDRA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001654954-24-008177 Act: 34 Size: 453 KB 网页链接
$恩德拉生命科学(NDRA)$ ARS Annual Report to Security Holders Accession Number: 0001654954-24-008178 Act: 34 Size: 12 MB 网页链接
$恩德拉生命科学(NDRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001079973-24-000884 Act: 34 Size: 41 KB 网页链接
$恩德拉生命科学(NDRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001079973-24-000877 Act: 34 Size: 40 KB 网页链接
$恩德拉生命科学(NDRA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001654954-24-007669 Act: 34 Size: 1 MB 网页链接
$恩德拉生命科学(NDRA)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001654954-24-007415 Act: 34 Size: 186 KB 网页链接
$恩德拉生命科学(NDRA)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001654954-24-007367 Act: 33 Size: 372 KB 网页链接
$恩德拉生命科学(NDRA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001735 Act: 33 Size: 1 KB 网页链接
$恩德拉生命科学(NDRA)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001654954-24-007150 Act: 33 Size: 804 KB 网页链接